Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population

BACKGROUND: Vulvovaginitis (VV) is a common reason women seek medical attention in the USA. Both the non-specific clinical presentation and risk of preterm labor or delivery necessitate accurate identification of the causative agents to guide appropriate therapy. The diagnostic accuracy of amplified...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackerman, Stacey J, Knight, Tyler, Wahl, Peter M, Cartwright, Charles P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388970/
https://www.ncbi.nlm.nih.gov/pubmed/30863131
http://dx.doi.org/10.2147/CEOR.S191831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388970/
https://www.ncbi.nlm.nih.gov/pubmed/30863131
http://dx.doi.org/10.2147/CEOR.S191831

Ejemplares similares